Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.

Research output: Contribution to journalJournal articleResearch

  1. The effect of insulin and glucagon on splanchnic oxygen consumption

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Meta-analysis of propylthiouracil for alcoholic liver disease--a Cochrane Hepato-Biliary Group Review

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Chinese medicinal herbs for chronic hepatitis B: a systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Poor concordance between liver stiffness and non-invasive fibrosis scores in HIV infection without viral hepatitis

    Research output: Contribution to journalShort surveyResearchpeer-review

  2. Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
AIMS/BACKGROUND: Cirrhotic patients exhibit a hyperdynamic and hyporeactive circulation with central hypovolaemia which may influence the course of the disease. As terlipressin, a vasopressin analogue, may modify systemic haemodynamics in these patients, the aim of the present study was to assess the acute effects of terlipressin on central and systemic haemodynamics. METHODS: Sixteen patients with alcoholic cirrhosis and portal hypertension had their systemic, central, and splanchnic haemodynamics determined at baseline and after a blind randomised bolus infusion (2 mg) of terlipressin/placebo. RESULTS: After terlipressin, the arterial blood pressure and the systemic vascular resistance increased by 26% and 61%, respectively (both p<0.001), and the cardiac output, heart rate, and arterial compliance decreased by 18%, 11%, and 32%, respectively (all p<0.001). The central circulation time increased by 36% (p<0.001), whereas the central and arterial blood volume only increased by 4% (p= 0.07). As expected, both portal pressure and hepatic blood flow decreased (17% and 29%, both p<0.001). The decrease in portal pressure after terlipressin was significantly related to the increase in systemic vascular resistance (r=-0.52, p<0.05) and the central circulation time (r=-0.80, p<0.0001). CONCLUSIONS: Terlipressin significantly attenuates the hyperdynamic circulation in portal hypertensive patients without a further contraction of the central and arterial blood volume. The systemic haemodynamic response to terlipressin is moreover associated with the decrease in portal pressure. Terlipressin may therefore have potentially beneficial effects on the hyperdynamic circulation in cirrhosis in addition to its effects on portal pressure.
Translated title of the contributionCentral and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
Original languageEnglish
JournalLiver
Volume20
Issue number1
Pages (from-to)51-59
Number of pages9
ISSN0106-9543
Publication statusPublished - 2000

ID: 32547568